These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30092464)

  • 1. Predicting the Occurrence of Hemorrhagic Cerebral Hyperperfusion Syndrome Using Regional Cerebral Blood Flow After Direct Bypass Surgery in Patients with Moyamoya Disease.
    Ishikawa T; Yamaguchi K; Kawashima A; Funatsu T; Eguchi S; Matsuoka G; Nomura S; Kawamata T
    World Neurosurg; 2018 Nov; 119():e750-e756. PubMed ID: 30092464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
    Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
    Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Moyamoya Disease: Region-Symptom Mapping and Estimating a Critical Threshold.
    Kazumata K; Uchino H; Tokairin K; Ito M; Shiga T; Osanai T; Kawabori M
    World Neurosurg; 2018 Jun; 114():e388-e395. PubMed ID: 29530706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease.
    Iwaki K; Takagishi S; Arimura K; Murata M; Chiba T; Nishimura A; Ren N; Iihara K
    Cerebrovasc Dis; 2021; 50(2):208-215. PubMed ID: 33596563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
    Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
    Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease.
    Kazumata K; Tha KK; Uchino H; Shiga T; Shichinohe H; Ito M; Nakayama N; Abumiya T
    J Neurosurg; 2017 Aug; 127(2):260-269. PubMed ID: 27588593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors of Delayed Hyperperfusion and the Importance of Repeated Cerebral Blood Flow Evaluation for Hyperperfusion After Direct Bypass for Moyamoya Disease.
    Nomura S; Yamaguchi K; Ishikawa T; Kawashima A; Okada Y; Kawamata T
    World Neurosurg; 2018 Oct; 118():e468-e472. PubMed ID: 29990604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
    Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of intraoperative laser Doppler flowmetry and thermography to predict a risk of postoperative hyperperfusion after superficial temporal artery-middle cerebral artery bypass for moyamoya disease.
    Kawamata T; Kawashima A; Yamaguchi K; Hori T; Okada Y
    Neurosurg Rev; 2011 Jul; 34(3):355-62; discussion 362. PubMed ID: 21643682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
    Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-Contrast Magnetic Resonance Imaging Analysis of Cerebral Hyperperfusion Syndrome After Surgery in Adult Patients with Moyamoya Disease.
    Gao F; Zhao W; Zheng Y; Li S; Lin G; Ji M; Duan Y; Li J; Hua Y
    World Neurosurg; 2019 Sep; 129():e48-e55. PubMed ID: 31051310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood flow measurement as an indicator for an indirect revascularization procedure for adult patients with moyamoya disease.
    Kohno K; Oka Y; Kohno S; Ohta S; Kumon Y; Sakaki S
    Neurosurgery; 1998 Apr; 42(4):752-7; discussion 757-8. PubMed ID: 9574639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative transit-time ultrasonography combined with FLOW800 predicts the occurrence of cerebral hyperperfusion syndrome after direct revascularization of Moyamoya disease: a preliminary study.
    Yang D; Zhang X; Tan C; Han Z; Su Y; Duan R; Shi G; Shao J; Cao P; He S; Wang R
    Acta Neurochir (Wien); 2021 Feb; 163(2):563-571. PubMed ID: 33006072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.